Company: PFSA
Filing Date: 2025-08-11
Form Type: S-1
Source: 0001213900-25-073872
Chunk: 297

Company: Profusa, Inc.
Filing Date: 2025-08-11
Form: S-1
Chunk 297
---
0.1million in lease expense for each of the three months ended March 31, 2025 and 2024. Contingencies and Indemnifications From time to time, the Company may have certain contingent liabilities that arise in the ordinary course of its business activities. The Company accrues a liability for such matters when it is probable that future expenditures will be made and that such expenditures can be reasonably estimated. Significant judgment is required to determine both probability and the estimated amount.

F-43

PROFUSA, INC. AND SUBSIDIARY
NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(UNAUDITED) Note 6 — Commitments and Contingencies (cont.) In the normal course of business, the Company enters into contracts and agreements that contain a variety of representations and warranties and provide for general indemnifications. The Company’s exposure under these agreements is unknown because it involves claims that may be made against the Company in the future, but that have not yet been made. To date, the Company has not paid any claims; however, the Company may record charges in the future as a result of these indemnification obligations. The Company is currently defending onelitigation with a vendor. Management has accrued estimated incremental legal costs which totals less than $ 0.1million related to the matter.

Note 7 — Convertible Preferred Stock

Under the Company’s Amended and Restated Certificate of Incorporation, as amended, (the “Company Charter”), the Company is authorized to issue two classes of shares: preferred and common stock. The preferred stock is issuable in series, and the Company’s Board of Directors is authorized to determine the rights, preferences, and terms of each series. Under the Company’s Charter, the Company is authorized to issue shares of convertible preferred stock at a par value of $.

Convertible preferred stock as of March 31, 2025 and December 31, 2024 consisted of the following:

|                |     |     Shares 
 Authorized |     |       Share 
  Issued and 
 Outstanding |     | Liquidation 
 Preference  |        |     | Carrying 
 Amount   |        |     | Original    
 Issue Price |      |
|:---------------|:----|-----------:|:----|------------:|:----|:------------|-------:|:----|:---------|-------:|:----|:------------|-----:|
| New Series A   |     |  4,350,314